New Vancouver-based fund has $100M to invest in biotech; FDA hands out $23M in rare disease R&D grants
The Chinese investment bank GF Securities has teamed with Quark Venture in Vancouver to launch a new biotech fund, starting with $100 million with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
